GBA1 and Parkinson disease: In addition to several studies demonstrating the UPR in animal models of GD and of GBA1-related PD, which are detailed in the previous references [3,4,8], the GBA1 D409V knock-out mouse model shows markedly reduced GCase activity in the liver and brain, with glycosphingolipid accumulation, but not UPR.